Detalhe da pesquisa
1.
Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study.
J Infect Dis
; 229(2): 355-366, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699064
2.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
J Infect Dis
; 227(6): 761-772, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904987
3.
Immunogenicity and safety following one dose of AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine in older adults: a phase 3 trial.
J Infect Dis
; 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38099559
4.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283213
5.
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 381(25): 2429-2439, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31661198
6.
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.
Immunity
; 38(4): 742-53, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23601686
7.
The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
J Infect Dis
; 224(7): 1139-1146, 2021 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32103273
8.
Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination.
J Infect Dis
; 224(12): 2025-2034, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502272
9.
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.
Clin Infect Dis
; 70(2): 181-190, 2020 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30843046
10.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.
Cancer
; 125(8): 1301-1312, 2019 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707761
11.
Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults.
J Viral Hepat
; 26(9): 1066-1075, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31087382
12.
Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.
J Infect Dis
; 217(11): 1750-1760, 2018 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29529222
13.
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-É£ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
J Immunol Methods
; 523: 113584, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37918618
14.
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.
Front Immunol
; 14: 1260146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936699
15.
2022 White Paper on Recent Issues in Bioanalysis: Enzyme Assay Validation, BAV for Primary End Points, Vaccine Functional Assays, Cytometry in Tissue, LBA in Rare Matrices, Complex NAb Assays, Spectral Cytometry, Endogenous Analytes, Extracellular Vesicles Part 2 - Recommendations on Biomarkers/CDx, Flow Cytometry, Ligand-Binding Assays Development & Validation; Emerging Technologies; Critical Reagents Deep Characterization.
Bioanalysis
; 15(15): 861-903, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584363
16.
Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium.
Front Immunol
; 13: 982887, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341380
17.
Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial.
Lancet Infect Dis
; 22(7): 1062-1075, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461522
18.
Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase.
J Biol Chem
; 285(27): 20481-91, 2010 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20427269
19.
Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.
J Transl Med
; 9: 44, 2011 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21507256
20.
Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.
Hum Vaccin Immunother
; 17(11): 4132-4143, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34190658